新生儿低血糖临床规范管理专家共识（2021）

Expert consensus on standard clinical management of neonatal hypoglycemia in China(2021)

摘要:

新生儿低血糖高危因素众多，严重持续的低血糖会导致不可逆的神经系统损伤，给家庭及社会带来极大负担。早期规范的预防及临床管理可有效降低新生儿低血糖及低血糖所致脑损伤的发生率。然而，目前国内尚无统一的新生儿低血糖临床管理指南，不同医疗机构借鉴不同的国外指南对新生儿低血糖进行临床管理，差异性较大。为进一步规范新生儿低血糖临床管理，由中华医学会儿科学分会新生儿学组制定了该共识。该共识针对胎龄35周及以上新生儿低血糖的预防、监测和管理的相关临床问题提出了21条推荐意见。

Abstract:

There are many high-risk factors for neonatal hypoglycemia, and persistent severe hypoglycemia can lead to irreversible neurological damage and bring a great burden to family and society. Early standardized prevention and clinical management can effectively reduce the incidence rate of neonatal hypoglycemia and brain injury induced by hypoglycemia; however at present, there is still a lack of unified clinical management guidelines for neonatal hypoglycemia in China, and different medical institutions follow different clinical guidelines developed by other countries for the management of neonatal hypoglycemia. In order to further standardize the clinical management of neonatal hypoglycemia, this consensus is developed by the Group of Neonatology, Pediatric Society, Chinese Medical Association. This consensus provides 21 recommendations to address related clinical issues in the prevention, monitoring, and management of hypoglycemia in neonates with a gestational age of ≥35 weeks.